Skip to main content
Top
Published in: Diabetologia 9/2016

01-09-2016 | Commentary

Can genetic evidence help us to understand the fetal origins of type 2 diabetes?

Author: Rachel M. Freathy

Published in: Diabetologia | Issue 9/2016

Login to get access

Abstract

Lower birthweight is consistently associated with a higher risk of type 2 diabetes in observational studies, but the mechanisms underlying this association are not fully understood. Animal models and studies of famine-exposed populations have provided support for the developmental origins hypothesis, under which exposure to poor intrauterine nutrition results in reduced fetal growth and also contributes to the developmental programming of later type 2 diabetes risk. However, testing this hypothesis is difficult in human studies and studies aiming to do so are mostly observational and have limited scope for causal inference due to the presence of confounding factors. In this issue of Diabetologia, Wang et al (doi: 10.​1007/​s00125-016-4019-z) have used genetic variation associated with birthweight in a Mendelian randomisation analysis to assess evidence of a causal link between fetal growth and type 2 diabetes. Mendelian randomisation offers the potential to examine associations between exposures and outcomes in the absence of factors that would normally confound observational studies. This commentary discusses the results of the Mendelian randomisation study carried out by Wang et al, in relation to the study design and its limitations. Challenges and opportunities for future studies are also outlined.
Literature
2.
go back to reference Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A (2007) Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 165:849–857CrossRefPubMed Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A (2007) Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 165:849–857CrossRefPubMed
3.
go back to reference de Rooij SR, Painter RC, Roseboom TJ et al (2006) Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia 49:637–643CrossRefPubMed de Rooij SR, Painter RC, Roseboom TJ et al (2006) Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia 49:637–643CrossRefPubMed
4.
go back to reference Poulsen P, Vaag AA, Kyvik KO, Moller Jensen D, Beck-Nielsen H (1997) Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 40:439–446CrossRefPubMed Poulsen P, Vaag AA, Kyvik KO, Moller Jensen D, Beck-Nielsen H (1997) Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 40:439–446CrossRefPubMed
5.
go back to reference Warner MJ, Ozanne SE (2010) Mechanisms involved in the developmental programming of adulthood disease. Biochem J 427:333–347CrossRefPubMed Warner MJ, Ozanne SE (2010) Mechanisms involved in the developmental programming of adulthood disease. Biochem J 427:333–347CrossRefPubMed
7.
go back to reference Davey Smith G, Ebrahim S (2003) ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:1–22CrossRef Davey Smith G, Ebrahim S (2003) ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:1–22CrossRef
8.
go back to reference Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH (2006) Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354:1264–1272CrossRefPubMed Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH (2006) Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354:1264–1272CrossRefPubMed
9.
go back to reference Horikoshi M, Yaghootkar H, Mook-Kanamori DO et al (2013) New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet 45:76–82CrossRefPubMed Horikoshi M, Yaghootkar H, Mook-Kanamori DO et al (2013) New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet 45:76–82CrossRefPubMed
10.
go back to reference Replication DIG, Meta-analysis C, Asian Genetic Epidemiology Network Type 2 Diabetes C et al (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 46:234–244CrossRef Replication DIG, Meta-analysis C, Asian Genetic Epidemiology Network Type 2 Diabetes C et al (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 46:234–244CrossRef
11.
go back to reference Haycock PC, Burgess S, Wade KH, Bowden J, Relton C, Davey Smith G (2016) Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am J Clin Nutr. doi:10.3945/ajcn.115.118216 Haycock PC, Burgess S, Wade KH, Bowden J, Relton C, Davey Smith G (2016) Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am J Clin Nutr. doi:10.​3945/​ajcn.​115.​118216
12.
13.
go back to reference Hattersley AT, Tooke JE (1999) The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 353:1789–1792CrossRefPubMed Hattersley AT, Tooke JE (1999) The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 353:1789–1792CrossRefPubMed
14.
go back to reference Johnson AD, Newton-Cheh C, Chasman DI et al (2011) Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension 57:903–910CrossRefPubMedPubMedCentral Johnson AD, Newton-Cheh C, Chasman DI et al (2011) Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension 57:903–910CrossRefPubMedPubMedCentral
15.
go back to reference Lango Allen H, Estrada K, Lettre G et al (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467:832–838CrossRefPubMedPubMedCentral Lango Allen H, Estrada K, Lettre G et al (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467:832–838CrossRefPubMedPubMedCentral
16.
go back to reference Kilpelainen TO, Carli JF, Skowronski AA et al (2016) Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nat Commun 7:10494CrossRefPubMedPubMedCentral Kilpelainen TO, Carli JF, Skowronski AA et al (2016) Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nat Commun 7:10494CrossRefPubMedPubMedCentral
17.
go back to reference Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512–525CrossRefPubMedPubMedCentral Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512–525CrossRefPubMedPubMedCentral
18.
go back to reference Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S (1998) Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 19:268–270CrossRefPubMed Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S (1998) Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 19:268–270CrossRefPubMed
19.
go back to reference Tyrrell J, Richmond RC, Palmer TM et al (2016) Genetic evidence for causal relationships between maternal obesity-related traits and birth weight. JAMA 315:1129–1140CrossRefPubMed Tyrrell J, Richmond RC, Palmer TM et al (2016) Genetic evidence for causal relationships between maternal obesity-related traits and birth weight. JAMA 315:1129–1140CrossRefPubMed
20.
go back to reference Burgess S, Davies NM, Thompson SG, Consortium EP-I (2014) Instrumental variable analysis with a nonlinear exposure-outcome relationship. Epidemiology 25:877–885CrossRefPubMedPubMedCentral Burgess S, Davies NM, Thompson SG, Consortium EP-I (2014) Instrumental variable analysis with a nonlinear exposure-outcome relationship. Epidemiology 25:877–885CrossRefPubMedPubMedCentral
Metadata
Title
Can genetic evidence help us to understand the fetal origins of type 2 diabetes?
Author
Rachel M. Freathy
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 9/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-4057-6

Other articles of this Issue 9/2016

Diabetologia 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.